KCNA2 IgG autoimmunity in neuropsychiatric diseases

• DOI: 10.1016/j.bbi.2024.01.220
• Publication Date: 2024-02-02T06:04:56Z
• Authors: Friederike A. Arlt; Ramona Miske; Marie-Luise Machule; Peter Broegger Ch...; Swantje Mindorf; Bianca Teegen; Kathrin Borowski; Maria Buthut; Rosa Rößling; Elisa Sánchez-Sendín; Scott van Hoof; César Cordero-Gómez; Isabel Bünger; Helena Radbruch; Andrea Kraft; Ilya Ayzenberg; Jaqueline Klausewitz; Niels Hansen; Charles Timäus; Peter Körtvelyessy; Thomas Postert; Kirsten Baur-Seack; Constanze Rost; Robert Brunkhorst; Kathrin Doppler; Niklas Haigis; Gerhard Hamann; Albrecht Kunze; Alexandra Stützer; Matthias Maschke; Nico Melzer; Felix Rosenow; Kai Siebenbrodt; Christian Stenør; Martin Dichgans; Marios K. Georgakis; Rong Fang; Gabor C. Petzold; Michael Görtler; Inga Zerr; Silke Wunderlich; Ivan Mihaljevic; Paul Turko; Marianne Schmidt ...; Emilie Buchholz; Helle Foverskov R...; Mahoor Nasouti; Ivan Talucci; Hans M. Maric; Stefan H. Heinemann; Matthias Endres; Lars Komorowski; Harald Prüss
• Keywords: Subfamily; Pathophysiology

Autoantibodies against the potassium voltage-gated channel subfamily A member 2 (KCNA2) have been described in a few cases of neuropsychiatric disorders, but their diagnostic and pathophysiological role is currently unknown, imposing challenges to medical practice.